As of 2025-08-03, the Fair Value of Mereo BioPharma Group plc (MREO) is -1.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.66 USD, the upside of Mereo BioPharma Group plc is -203.80%.
With the market price of 1.66 USD and our fair value calculation, Mereo BioPharma Group plc (MREO) is not a good investment. Investing in MREO stocks now will result in a potential loss of 203.80%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -209.80 | 17.50 | -42.13 | -29.47 | -43.25 | -61.43 |
| YoY growth | -371.85% | 108.34% | -340.76% | 30.06% | -46.79% | -124.20% |
| Market Cap (mil) | 276.66 |
| P/E | |
| Forward P/E |
| EPS | -0.26 |
| Avg earnings growth rate | -124.20% |
| TTM earnings | -43.25 |